The Ensign Group, Inc. reported $5.46B of revenue over the trailing twelve months, +19% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.46B (to Q2 2026). Net income: $379M, trailing twelve months to Q2 2026. Operating margin: 8.5%, trailing twelve months to Q2 2026. EPS: $6.38, trailing twelve months to Q2 2026.

ENSGThe Ensign Group, Inc.

Healthcare

$171.78+4.7% 1Y

$171.78

$147.1352 weeks$215.76

ENSG as reported

The Ensign Group, Inc. reported $5.46B of revenue over the trailing twelve months, +19% on the year before. 11 reported series are charted on this page, each one as filed.

$5.46B

Revenue, trailing twelve months · to Q2 2026 · +19% against the twelve months before

Net income: $379M
Net income · +17% year on year · trailing twelve months to Q2 2026
Operating margin: 8.5%
Operating margin · trailing twelve months to Q2 2026
EPS: $6.38
EPS · +16% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ENSG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.46B	+19%	Q2 2026
Net income	$379M	+17%	Q2 2026
EPS	$6.38	+16%	Q2 2026
Gross margin	20%	n/a	Q2 2026
Operating margin	8.5%	n/a	Q2 2026
Net margin	6.9%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	6.4%	n/a	Q2 2026
ROIC	18%	n/a	Q2 2026
Free cash flow	$121M	n/a	Q4 2019 · 26 quarters behind
P/E	26.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.